362 related articles for article (PubMed ID: 22682881)
1. Cancer and contraception. Release date May 2012. SFP Guideline #20121.
Patel A; Schwarz EB;
Contraception; 2012 Sep; 86(3):191-8. PubMed ID: 22682881
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
3. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
4. [Post-coital contraception].
Serfaty D
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
[TBL] [Abstract][Full Text] [Related]
5. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
Boutet G
Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
7. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of IUDs is increasing.
Finger WR; Barr D
Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception: state of the art and future perspectives.
Benagiano G; Bastianelli C; Farris M
Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403
[TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
[TBL] [Abstract][Full Text] [Related]
11. Contraception for cancer survivors.
Schwarz EB; Hess R; Trussell J
J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S401-6. PubMed ID: 19838839
[TBL] [Abstract][Full Text] [Related]
12. Contraception choices in women with underlying medical conditions.
Bonnema RA; McNamara MC; Spencer AL
Am Fam Physician; 2010 Sep; 82(6):621-8. PubMed ID: 20842989
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraception.
Baird DT; Glasier AF
N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of the LNG IUS, and counseling.
Pakarinen P; Toivonen J; Luukkainen T
Semin Reprod Med; 2001 Dec; 19(4):365-72. PubMed ID: 11727178
[TBL] [Abstract][Full Text] [Related]
15. Current challenges in contraception in adolescents and young women.
Cornet A
Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
[TBL] [Abstract][Full Text] [Related]
16. New approaches seek greater safety, appeal.
Blaney CL
Netw Res Triangle Park N C; 1995 Jun; 15(4):26-9. PubMed ID: 12289831
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
Gemzell-Danielsson K; Inki P; Heikinheimo O
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
Kesim MD; Aydin Y; Atis A; Mandiraci G
Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
[TBL] [Abstract][Full Text] [Related]
19. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.
Bahamondes L; Valeria Bahamondes M; Shulman LP
Hum Reprod Update; 2015; 21(5):640-51. PubMed ID: 26037216
[TBL] [Abstract][Full Text] [Related]
20. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
